Transcode Therapeutics, Inc. - RNAZ

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 20
Latest filed: Sep 11, 2026
Form Count
8-K 9
SCHEDULE 13D/A 4
SCHEDULE 13G 4
4 2
8-K/A 1

Latest files

Filed Form Report period Accession SEC
Sep 11, 2026 8-K Sep 09, 2026 0001104659-26-107115 View
Sep 11, 2026 4 Sep 09, 2026 0001104659-26-107120 View
Aug 05, 2026 4 Aug 03, 2026 0001104659-26-091078 View
Aug 03, 2026 8-K Aug 03, 2026 0001104659-26-089805 View
Aug 03, 2026 SCHEDULE 13D/A — 0001104659-26-089819 View
Jul 28, 2026 SCHEDULE 13G — 0001493152-26-035074 View
Jul 28, 2026 SCHEDULE 13G — 0001493152-26-035075 View
Jul 28, 2026 SCHEDULE 13G — 0001493152-26-035076 View
Jul 27, 2026 SCHEDULE 13D/A — 0001104659-26-087098 View
Jul 23, 2026 SCHEDULE 13D/A — 0001104659-26-086266 View
Jul 20, 2026 8-K Jul 20, 2026 0001104659-26-085073 View
Jul 17, 2026 8-K Jul 16, 2026 0001104659-26-084617 View
Jul 17, 2026 SCHEDULE 13D/A — 0001104659-26-084636 View
Jul 02, 2026 8-K Jul 02, 2026 0001104659-26-080311 View
Jun 18, 2026 8-K Jun 18, 2026 0001104659-26-075440 View
Jun 03, 2026 8-K Jun 03, 2026 0001104659-26-069810 View
Jun 01, 2026 8-K May 29, 2026 0001104659-26-068647 View
May 26, 2026 8-K/A May 19, 2026 0001104659-26-065959 View
May 22, 2026 8-K May 19, 2026 0001104659-26-065728 View
Apr 20, 2026 SCHEDULE 13G — 0001104659-26-045551 View